nodes	percent_of_prediction	percent_of_DWPC	metapath
Etoricoxib—PTGS2—Barrett's esophagus	0.373	1	CbGaD
Etoricoxib—CYP2C19—Esomeprazole—Barrett's esophagus	0.11	0.26	CbGbCtD
Etoricoxib—CYP2C19—Omeprazole—Barrett's esophagus	0.0649	0.154	CbGbCtD
Etoricoxib—CYP1A2—Omeprazole—Barrett's esophagus	0.0599	0.142	CbGbCtD
Etoricoxib—CYP2C9—Omeprazole—Barrett's esophagus	0.0539	0.128	CbGbCtD
Etoricoxib—CYP3A4—Esomeprazole—Barrett's esophagus	0.0532	0.126	CbGbCtD
Etoricoxib—CYP2D6—Omeprazole—Barrett's esophagus	0.0493	0.117	CbGbCtD
Etoricoxib—CYP3A4—Omeprazole—Barrett's esophagus	0.0314	0.0742	CbGbCtD
Etoricoxib—Functional gastrointestinal disorder—Omeprazole—Barrett's esophagus	0.00374	0.023	CcSEcCtD
Etoricoxib—Oral disorder—Esomeprazole—Barrett's esophagus	0.00374	0.023	CcSEcCtD
Etoricoxib—PTGS2—Synthesis of Prostaglandins (PG) and Thromboxanes (TX)—PTGES—Barrett's esophagus	0.00209	0.054	CbGpPWpGaD
Etoricoxib—Nephrotic syndrome—Omeprazole—Barrett's esophagus	0.00196	0.012	CcSEcCtD
Etoricoxib—Nephrotic syndrome—Esomeprazole—Barrett's esophagus	0.00196	0.012	CcSEcCtD
Etoricoxib—Tongue oedema—Omeprazole—Barrett's esophagus	0.00169	0.0104	CcSEcCtD
Etoricoxib—Tongue oedema—Esomeprazole—Barrett's esophagus	0.00169	0.0104	CcSEcCtD
Etoricoxib—Polyp—Omeprazole—Barrett's esophagus	0.00155	0.00955	CcSEcCtD
Etoricoxib—Polyp—Esomeprazole—Barrett's esophagus	0.00155	0.00955	CcSEcCtD
Etoricoxib—Cyst—Esomeprazole—Barrett's esophagus	0.00141	0.00869	CcSEcCtD
Etoricoxib—Cyst—Omeprazole—Barrett's esophagus	0.00141	0.00869	CcSEcCtD
Etoricoxib—Nephritis interstitial—Omeprazole—Barrett's esophagus	0.0014	0.00861	CcSEcCtD
Etoricoxib—Nephritis interstitial—Esomeprazole—Barrett's esophagus	0.0014	0.00861	CcSEcCtD
Etoricoxib—PTGS2—Eicosanoid Synthesis—PTGES—Barrett's esophagus	0.00136	0.0351	CbGpPWpGaD
Etoricoxib—Tongue disorder—Omeprazole—Barrett's esophagus	0.0013	0.00799	CcSEcCtD
Etoricoxib—Tongue disorder—Esomeprazole—Barrett's esophagus	0.0013	0.00799	CcSEcCtD
Etoricoxib—Tubulointerstitial nephritis—Omeprazole—Barrett's esophagus	0.00123	0.00759	CcSEcCtD
Etoricoxib—Tubulointerstitial nephritis—Esomeprazole—Barrett's esophagus	0.00123	0.00759	CcSEcCtD
Etoricoxib—Fungal infection—Esomeprazole—Barrett's esophagus	0.00122	0.00752	CcSEcCtD
Etoricoxib—Fungal infection—Omeprazole—Barrett's esophagus	0.00122	0.00752	CcSEcCtD
Etoricoxib—Glycosuria—Omeprazole—Barrett's esophagus	0.00117	0.00717	CcSEcCtD
Etoricoxib—Glycosuria—Esomeprazole—Barrett's esophagus	0.00117	0.00717	CcSEcCtD
Etoricoxib—Celecoxib—PTGS2—Barrett's esophagus	0.00113	1	CrCbGaD
Etoricoxib—Proteinuria—Omeprazole—Barrett's esophagus	0.00108	0.00661	CcSEcCtD
Etoricoxib—Proteinuria—Esomeprazole—Barrett's esophagus	0.00108	0.00661	CcSEcCtD
Etoricoxib—Protein urine present—Esomeprazole—Barrett's esophagus	0.00106	0.00652	CcSEcCtD
Etoricoxib—Protein urine present—Omeprazole—Barrett's esophagus	0.00106	0.00652	CcSEcCtD
Etoricoxib—Gastrooesophageal reflux disease—Esomeprazole—Barrett's esophagus	0.00105	0.00643	CcSEcCtD
Etoricoxib—Gastrooesophageal reflux disease—Omeprazole—Barrett's esophagus	0.00105	0.00643	CcSEcCtD
Etoricoxib—MAPK14—IL6-mediated signaling events—MCL1—Barrett's esophagus	0.00103	0.0266	CbGpPWpGaD
Etoricoxib—Blood uric acid increased—Esomeprazole—Barrett's esophagus	0.000962	0.00592	CcSEcCtD
Etoricoxib—Blood uric acid increased—Omeprazole—Barrett's esophagus	0.000962	0.00592	CcSEcCtD
Etoricoxib—Phosphatase alkaline increased—Omeprazole—Barrett's esophagus	0.000945	0.00581	CcSEcCtD
Etoricoxib—Blood pressure increased—Esomeprazole—Barrett's esophagus	0.000945	0.00581	CcSEcCtD
Etoricoxib—Phosphatase alkaline increased—Esomeprazole—Barrett's esophagus	0.000945	0.00581	CcSEcCtD
Etoricoxib—Blood pressure increased—Omeprazole—Barrett's esophagus	0.000945	0.00581	CcSEcCtD
Etoricoxib—Cystitis noninfective—Omeprazole—Barrett's esophagus	0.000923	0.00568	CcSEcCtD
Etoricoxib—Cystitis noninfective—Esomeprazole—Barrett's esophagus	0.000923	0.00568	CcSEcCtD
Etoricoxib—Melaena—Omeprazole—Barrett's esophagus	0.000923	0.00568	CcSEcCtD
Etoricoxib—Melaena—Esomeprazole—Barrett's esophagus	0.000923	0.00568	CcSEcCtD
Etoricoxib—Cystitis—Omeprazole—Barrett's esophagus	0.000912	0.00561	CcSEcCtD
Etoricoxib—Cystitis—Esomeprazole—Barrett's esophagus	0.000912	0.00561	CcSEcCtD
Etoricoxib—Vaginal infection—Omeprazole—Barrett's esophagus	0.000892	0.00549	CcSEcCtD
Etoricoxib—Vaginal infection—Esomeprazole—Barrett's esophagus	0.000892	0.00549	CcSEcCtD
Etoricoxib—MAPK14—Signaling mediated by p38-alpha and p38-beta—SLC9A1—Barrett's esophagus	0.000859	0.0222	CbGpPWpGaD
Etoricoxib—Mouth ulceration—Esomeprazole—Barrett's esophagus	0.000854	0.00525	CcSEcCtD
Etoricoxib—Mouth ulceration—Omeprazole—Barrett's esophagus	0.000854	0.00525	CcSEcCtD
Etoricoxib—Bladder pain—Esomeprazole—Barrett's esophagus	0.000854	0.00525	CcSEcCtD
Etoricoxib—Neoplasm—Esomeprazole—Barrett's esophagus	0.000854	0.00525	CcSEcCtD
Etoricoxib—Bladder pain—Omeprazole—Barrett's esophagus	0.000854	0.00525	CcSEcCtD
Etoricoxib—Neoplasm—Omeprazole—Barrett's esophagus	0.000854	0.00525	CcSEcCtD
Etoricoxib—Blood alkaline phosphatase increased—Omeprazole—Barrett's esophagus	0.000789	0.00485	CcSEcCtD
Etoricoxib—Blood alkaline phosphatase increased—Esomeprazole—Barrett's esophagus	0.000789	0.00485	CcSEcCtD
Etoricoxib—Gastroenteritis—Esomeprazole—Barrett's esophagus	0.000774	0.00476	CcSEcCtD
Etoricoxib—Gastroenteritis—Omeprazole—Barrett's esophagus	0.000774	0.00476	CcSEcCtD
Etoricoxib—Hepatic failure—Omeprazole—Barrett's esophagus	0.000763	0.00469	CcSEcCtD
Etoricoxib—Hepatic failure—Esomeprazole—Barrett's esophagus	0.000763	0.00469	CcSEcCtD
Etoricoxib—PTGS2—Arachidonic acid metabolism—PTGES—Barrett's esophagus	0.000755	0.0195	CbGpPWpGaD
Etoricoxib—Injury—Omeprazole—Barrett's esophagus	0.000746	0.00459	CcSEcCtD
Etoricoxib—Injury—Esomeprazole—Barrett's esophagus	0.000746	0.00459	CcSEcCtD
Etoricoxib—CYP2E1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP26A1—Barrett's esophagus	0.000733	0.0189	CbGpPWpGaD
Etoricoxib—CYP2E1—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—Barrett's esophagus	0.000733	0.0189	CbGpPWpGaD
Etoricoxib—Visual disturbance—Esomeprazole—Barrett's esophagus	0.000724	0.00445	CcSEcCtD
Etoricoxib—Visual disturbance—Omeprazole—Barrett's esophagus	0.000724	0.00445	CcSEcCtD
Etoricoxib—Renal impairment—Omeprazole—Barrett's esophagus	0.000721	0.00443	CcSEcCtD
Etoricoxib—Thirst—Omeprazole—Barrett's esophagus	0.000721	0.00443	CcSEcCtD
Etoricoxib—Thirst—Esomeprazole—Barrett's esophagus	0.000721	0.00443	CcSEcCtD
Etoricoxib—Renal impairment—Esomeprazole—Barrett's esophagus	0.000721	0.00443	CcSEcCtD
Etoricoxib—Pain in extremity—Esomeprazole—Barrett's esophagus	0.000686	0.00422	CcSEcCtD
Etoricoxib—Gastrointestinal haemorrhage—Omeprazole—Barrett's esophagus	0.000686	0.00422	CcSEcCtD
Etoricoxib—Pain in extremity—Omeprazole—Barrett's esophagus	0.000686	0.00422	CcSEcCtD
Etoricoxib—Gastrointestinal haemorrhage—Esomeprazole—Barrett's esophagus	0.000686	0.00422	CcSEcCtD
Etoricoxib—MAPK14—Atypical NF-kappaB pathway—RELA—Barrett's esophagus	0.000661	0.0171	CbGpPWpGaD
Etoricoxib—MAPK14—Cardiac Progenitor Differentiation—BMP4—Barrett's esophagus	0.000648	0.0167	CbGpPWpGaD
Etoricoxib—Blood creatinine increased—Omeprazole—Barrett's esophagus	0.000643	0.00395	CcSEcCtD
Etoricoxib—Blood creatinine increased—Esomeprazole—Barrett's esophagus	0.000643	0.00395	CcSEcCtD
Etoricoxib—Breast disorder—Esomeprazole—Barrett's esophagus	0.00062	0.00381	CcSEcCtD
Etoricoxib—Breast disorder—Omeprazole—Barrett's esophagus	0.00062	0.00381	CcSEcCtD
Etoricoxib—Toxic epidermal necrolysis—Esomeprazole—Barrett's esophagus	0.000618	0.0038	CcSEcCtD
Etoricoxib—Aspartate aminotransferase increased—Omeprazole—Barrett's esophagus	0.000618	0.0038	CcSEcCtD
Etoricoxib—Aspartate aminotransferase increased—Esomeprazole—Barrett's esophagus	0.000618	0.0038	CcSEcCtD
Etoricoxib—Cramp muscle—Esomeprazole—Barrett's esophagus	0.000618	0.0038	CcSEcCtD
Etoricoxib—Toxic epidermal necrolysis—Omeprazole—Barrett's esophagus	0.000618	0.0038	CcSEcCtD
Etoricoxib—Cramp muscle—Omeprazole—Barrett's esophagus	0.000618	0.0038	CcSEcCtD
Etoricoxib—CYP2E1—Vitamin A and Carotenoid Metabolism—CYP26A1—Barrett's esophagus	0.000608	0.0157	CbGpPWpGaD
Etoricoxib—Gastritis—Esomeprazole—Barrett's esophagus	0.000607	0.00373	CcSEcCtD
Etoricoxib—Gastritis—Omeprazole—Barrett's esophagus	0.000607	0.00373	CcSEcCtD
Etoricoxib—Alanine aminotransferase increased—Omeprazole—Barrett's esophagus	0.000605	0.00372	CcSEcCtD
Etoricoxib—Muscular weakness—Omeprazole—Barrett's esophagus	0.000605	0.00372	CcSEcCtD
Etoricoxib—Alanine aminotransferase increased—Esomeprazole—Barrett's esophagus	0.000605	0.00372	CcSEcCtD
Etoricoxib—Muscular weakness—Esomeprazole—Barrett's esophagus	0.000605	0.00372	CcSEcCtD
Etoricoxib—Abdominal distension—Omeprazole—Barrett's esophagus	0.000597	0.00367	CcSEcCtD
Etoricoxib—Abdominal distension—Esomeprazole—Barrett's esophagus	0.000597	0.00367	CcSEcCtD
Etoricoxib—CYP3A4—Drug Induction of Bile Acid Pathway—NR1I2—Barrett's esophagus	0.000592	0.0153	CbGpPWpGaD
Etoricoxib—Bronchospasm—Esomeprazole—Barrett's esophagus	0.000583	0.00359	CcSEcCtD
Etoricoxib—Bronchospasm—Omeprazole—Barrett's esophagus	0.000583	0.00359	CcSEcCtD
Etoricoxib—Pancreatitis—Esomeprazole—Barrett's esophagus	0.000581	0.00357	CcSEcCtD
Etoricoxib—Pancreatitis—Omeprazole—Barrett's esophagus	0.000581	0.00357	CcSEcCtD
Etoricoxib—Angina pectoris—Omeprazole—Barrett's esophagus	0.000577	0.00355	CcSEcCtD
Etoricoxib—Angina pectoris—Esomeprazole—Barrett's esophagus	0.000577	0.00355	CcSEcCtD
Etoricoxib—MAPK14—BDNF signaling pathway—CRTC1—Barrett's esophagus	0.000554	0.0143	CbGpPWpGaD
Etoricoxib—Upper respiratory tract infection—Esomeprazole—Barrett's esophagus	0.000551	0.00339	CcSEcCtD
Etoricoxib—Upper respiratory tract infection—Omeprazole—Barrett's esophagus	0.000551	0.00339	CcSEcCtD
Etoricoxib—PTGS2—Signaling mediated by p38-alpha and p38-beta—SLC9A1—Barrett's esophagus	0.000549	0.0142	CbGpPWpGaD
Etoricoxib—CYP2C19—Arachidonic acid metabolism—PTGES—Barrett's esophagus	0.000548	0.0142	CbGpPWpGaD
Etoricoxib—Photosensitivity reaction—Esomeprazole—Barrett's esophagus	0.000541	0.00333	CcSEcCtD
Etoricoxib—Photosensitivity reaction—Omeprazole—Barrett's esophagus	0.000541	0.00333	CcSEcCtD
Etoricoxib—Weight increased—Esomeprazole—Barrett's esophagus	0.00054	0.00332	CcSEcCtD
Etoricoxib—Weight increased—Omeprazole—Barrett's esophagus	0.00054	0.00332	CcSEcCtD
Etoricoxib—MAPK14—Endothelins—SLC9A1—Barrett's esophagus	0.000537	0.0139	CbGpPWpGaD
Etoricoxib—Infestation NOS—Omeprazole—Barrett's esophagus	0.000529	0.00325	CcSEcCtD
Etoricoxib—Infestation—Omeprazole—Barrett's esophagus	0.000529	0.00325	CcSEcCtD
Etoricoxib—Infestation NOS—Esomeprazole—Barrett's esophagus	0.000529	0.00325	CcSEcCtD
Etoricoxib—Infestation—Esomeprazole—Barrett's esophagus	0.000529	0.00325	CcSEcCtD
Etoricoxib—Stevens-Johnson syndrome—Omeprazole—Barrett's esophagus	0.000524	0.00322	CcSEcCtD
Etoricoxib—Stevens-Johnson syndrome—Esomeprazole—Barrett's esophagus	0.000524	0.00322	CcSEcCtD
Etoricoxib—Renal failure—Esomeprazole—Barrett's esophagus	0.00052	0.0032	CcSEcCtD
Etoricoxib—Renal failure—Omeprazole—Barrett's esophagus	0.00052	0.0032	CcSEcCtD
Etoricoxib—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—Barrett's esophagus	0.000516	0.0133	CbGpPWpGaD
Etoricoxib—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP26A1—Barrett's esophagus	0.000516	0.0133	CbGpPWpGaD
Etoricoxib—Jaundice—Esomeprazole—Barrett's esophagus	0.000515	0.00317	CcSEcCtD
Etoricoxib—Stomatitis—Esomeprazole—Barrett's esophagus	0.000515	0.00317	CcSEcCtD
Etoricoxib—Jaundice—Omeprazole—Barrett's esophagus	0.000515	0.00317	CcSEcCtD
Etoricoxib—Stomatitis—Omeprazole—Barrett's esophagus	0.000515	0.00317	CcSEcCtD
Etoricoxib—Urinary tract infection—Esomeprazole—Barrett's esophagus	0.000514	0.00316	CcSEcCtD
Etoricoxib—Conjunctivitis—Omeprazole—Barrett's esophagus	0.000514	0.00316	CcSEcCtD
Etoricoxib—Urinary tract infection—Omeprazole—Barrett's esophagus	0.000514	0.00316	CcSEcCtD
Etoricoxib—Conjunctivitis—Esomeprazole—Barrett's esophagus	0.000514	0.00316	CcSEcCtD
Etoricoxib—Haematuria—Esomeprazole—Barrett's esophagus	0.000504	0.0031	CcSEcCtD
Etoricoxib—Haematuria—Omeprazole—Barrett's esophagus	0.000504	0.0031	CcSEcCtD
Etoricoxib—CYP2C9—Arachidonic acid metabolism—PTGES—Barrett's esophagus	0.0005	0.0129	CbGpPWpGaD
Etoricoxib—Hepatobiliary disease—Esomeprazole—Barrett's esophagus	0.0005	0.00307	CcSEcCtD
Etoricoxib—Hepatobiliary disease—Omeprazole—Barrett's esophagus	0.0005	0.00307	CcSEcCtD
Etoricoxib—Epistaxis—Esomeprazole—Barrett's esophagus	0.000499	0.00307	CcSEcCtD
Etoricoxib—Epistaxis—Omeprazole—Barrett's esophagus	0.000499	0.00307	CcSEcCtD
Etoricoxib—Sinusitis—Esomeprazole—Barrett's esophagus	0.000496	0.00305	CcSEcCtD
Etoricoxib—Sinusitis—Omeprazole—Barrett's esophagus	0.000496	0.00305	CcSEcCtD
Etoricoxib—MAPK14—Cell-Cell communication—CDH13—Barrett's esophagus	0.00049	0.0127	CbGpPWpGaD
Etoricoxib—Hepatitis—Omeprazole—Barrett's esophagus	0.000475	0.00292	CcSEcCtD
Etoricoxib—Hepatitis—Esomeprazole—Barrett's esophagus	0.000475	0.00292	CcSEcCtD
Etoricoxib—Hypoaesthesia—Esomeprazole—Barrett's esophagus	0.000472	0.0029	CcSEcCtD
Etoricoxib—Hypoaesthesia—Omeprazole—Barrett's esophagus	0.000472	0.0029	CcSEcCtD
Etoricoxib—Hallucination—Omeprazole—Barrett's esophagus	0.000472	0.0029	CcSEcCtD
Etoricoxib—Hallucination—Esomeprazole—Barrett's esophagus	0.000472	0.0029	CcSEcCtD
Etoricoxib—Pharyngitis—Omeprazole—Barrett's esophagus	0.000471	0.0029	CcSEcCtD
Etoricoxib—Pharyngitis—Esomeprazole—Barrett's esophagus	0.000471	0.0029	CcSEcCtD
Etoricoxib—Urinary tract disorder—Omeprazole—Barrett's esophagus	0.000469	0.00288	CcSEcCtD
Etoricoxib—Urinary tract disorder—Esomeprazole—Barrett's esophagus	0.000469	0.00288	CcSEcCtD
Etoricoxib—Oedema peripheral—Omeprazole—Barrett's esophagus	0.000467	0.00287	CcSEcCtD
Etoricoxib—Oedema peripheral—Esomeprazole—Barrett's esophagus	0.000467	0.00287	CcSEcCtD
Etoricoxib—Connective tissue disorder—Omeprazole—Barrett's esophagus	0.000466	0.00287	CcSEcCtD
Etoricoxib—Connective tissue disorder—Esomeprazole—Barrett's esophagus	0.000466	0.00287	CcSEcCtD
Etoricoxib—CYP2E1—Cytochrome P450 - arranged by substrate type—CYP26A1—Barrett's esophagus	0.000466	0.012	CbGpPWpGaD
Etoricoxib—Urethral disorder—Omeprazole—Barrett's esophagus	0.000465	0.00286	CcSEcCtD
Etoricoxib—Urethral disorder—Esomeprazole—Barrett's esophagus	0.000465	0.00286	CcSEcCtD
Etoricoxib—CYP2E1—Oxidation by Cytochrome P450—CYP26A1—Barrett's esophagus	0.000459	0.0119	CbGpPWpGaD
Etoricoxib—Visual impairment—Omeprazole—Barrett's esophagus	0.000457	0.00281	CcSEcCtD
Etoricoxib—Visual impairment—Esomeprazole—Barrett's esophagus	0.000457	0.00281	CcSEcCtD
Etoricoxib—Erythema multiforme—Esomeprazole—Barrett's esophagus	0.000449	0.00276	CcSEcCtD
Etoricoxib—Erythema multiforme—Omeprazole—Barrett's esophagus	0.000449	0.00276	CcSEcCtD
Etoricoxib—Eye disorder—Esomeprazole—Barrett's esophagus	0.000443	0.00273	CcSEcCtD
Etoricoxib—Eye disorder—Omeprazole—Barrett's esophagus	0.000443	0.00273	CcSEcCtD
Etoricoxib—Tinnitus—Esomeprazole—Barrett's esophagus	0.000442	0.00272	CcSEcCtD
Etoricoxib—Tinnitus—Omeprazole—Barrett's esophagus	0.000442	0.00272	CcSEcCtD
Etoricoxib—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—Barrett's esophagus	0.000441	0.0114	CbGpPWpGaD
Etoricoxib—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP26A1—Barrett's esophagus	0.000441	0.0114	CbGpPWpGaD
Etoricoxib—Flushing—Omeprazole—Barrett's esophagus	0.00044	0.00271	CcSEcCtD
Etoricoxib—Flushing—Esomeprazole—Barrett's esophagus	0.00044	0.00271	CcSEcCtD
Etoricoxib—MAPK14—epithelium—Barrett's esophagus	0.000435	0.201	CbGeAlD
Etoricoxib—Immune system disorder—Omeprazole—Barrett's esophagus	0.000429	0.00264	CcSEcCtD
Etoricoxib—Immune system disorder—Esomeprazole—Barrett's esophagus	0.000429	0.00264	CcSEcCtD
Etoricoxib—Mediastinal disorder—Esomeprazole—Barrett's esophagus	0.000428	0.00263	CcSEcCtD
Etoricoxib—Mediastinal disorder—Omeprazole—Barrett's esophagus	0.000428	0.00263	CcSEcCtD
Etoricoxib—CYP1A2—Arachidonic acid metabolism—PTGES—Barrett's esophagus	0.000427	0.011	CbGpPWpGaD
Etoricoxib—MAPK14—smooth muscle tissue—Barrett's esophagus	0.00042	0.194	CbGeAlD
Etoricoxib—Alopecia—Omeprazole—Barrett's esophagus	0.000419	0.00258	CcSEcCtD
Etoricoxib—Alopecia—Esomeprazole—Barrett's esophagus	0.000419	0.00258	CcSEcCtD
Etoricoxib—Mental disorder—Omeprazole—Barrett's esophagus	0.000416	0.00256	CcSEcCtD
Etoricoxib—Mental disorder—Esomeprazole—Barrett's esophagus	0.000416	0.00256	CcSEcCtD
Etoricoxib—Malnutrition—Omeprazole—Barrett's esophagus	0.000413	0.00254	CcSEcCtD
Etoricoxib—Malnutrition—Esomeprazole—Barrett's esophagus	0.000413	0.00254	CcSEcCtD
Etoricoxib—Flatulence—Omeprazole—Barrett's esophagus	0.000407	0.0025	CcSEcCtD
Etoricoxib—Flatulence—Esomeprazole—Barrett's esophagus	0.000407	0.0025	CcSEcCtD
Etoricoxib—Dysgeusia—Omeprazole—Barrett's esophagus	0.000405	0.00249	CcSEcCtD
Etoricoxib—Dysgeusia—Esomeprazole—Barrett's esophagus	0.000405	0.00249	CcSEcCtD
Etoricoxib—Muscle spasms—Esomeprazole—Barrett's esophagus	0.000397	0.00244	CcSEcCtD
Etoricoxib—Muscle spasms—Omeprazole—Barrett's esophagus	0.000397	0.00244	CcSEcCtD
Etoricoxib—Vision blurred—Esomeprazole—Barrett's esophagus	0.000389	0.00239	CcSEcCtD
Etoricoxib—Vision blurred—Omeprazole—Barrett's esophagus	0.000389	0.00239	CcSEcCtD
Etoricoxib—Tremor—Omeprazole—Barrett's esophagus	0.000387	0.00238	CcSEcCtD
Etoricoxib—Tremor—Esomeprazole—Barrett's esophagus	0.000387	0.00238	CcSEcCtD
Etoricoxib—MAPK14—FGF signaling pathway—HGF—Barrett's esophagus	0.000387	0.00998	CbGpPWpGaD
Etoricoxib—Anaemia—Esomeprazole—Barrett's esophagus	0.000382	0.00235	CcSEcCtD
Etoricoxib—Anaemia—Omeprazole—Barrett's esophagus	0.000382	0.00235	CcSEcCtD
Etoricoxib—Agitation—Omeprazole—Barrett's esophagus	0.00038	0.00233	CcSEcCtD
Etoricoxib—Agitation—Esomeprazole—Barrett's esophagus	0.00038	0.00233	CcSEcCtD
Etoricoxib—Angioedema—Omeprazole—Barrett's esophagus	0.000377	0.00232	CcSEcCtD
Etoricoxib—Angioedema—Esomeprazole—Barrett's esophagus	0.000377	0.00232	CcSEcCtD
Etoricoxib—CYP2E1—Phase 1 - Functionalization of compounds—CYP26A1—Barrett's esophagus	0.000377	0.00974	CbGpPWpGaD
Etoricoxib—Palpitations—Omeprazole—Barrett's esophagus	0.000365	0.00224	CcSEcCtD
Etoricoxib—Palpitations—Esomeprazole—Barrett's esophagus	0.000365	0.00224	CcSEcCtD
Etoricoxib—Cough—Esomeprazole—Barrett's esophagus	0.00036	0.00222	CcSEcCtD
Etoricoxib—Cough—Omeprazole—Barrett's esophagus	0.00036	0.00222	CcSEcCtD
Etoricoxib—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP26A1—Barrett's esophagus	0.000359	0.00927	CbGpPWpGaD
Etoricoxib—Hypertension—Esomeprazole—Barrett's esophagus	0.000357	0.00219	CcSEcCtD
Etoricoxib—Hypertension—Omeprazole—Barrett's esophagus	0.000357	0.00219	CcSEcCtD
Etoricoxib—CYP2C19—Oxidation by Cytochrome P450—CYP26A1—Barrett's esophagus	0.000354	0.00915	CbGpPWpGaD
Etoricoxib—Chest pain—Esomeprazole—Barrett's esophagus	0.000352	0.00216	CcSEcCtD
Etoricoxib—Arthralgia—Omeprazole—Barrett's esophagus	0.000352	0.00216	CcSEcCtD
Etoricoxib—Chest pain—Omeprazole—Barrett's esophagus	0.000352	0.00216	CcSEcCtD
Etoricoxib—Arthralgia—Esomeprazole—Barrett's esophagus	0.000352	0.00216	CcSEcCtD
Etoricoxib—Anxiety—Esomeprazole—Barrett's esophagus	0.00035	0.00215	CcSEcCtD
Etoricoxib—Anxiety—Omeprazole—Barrett's esophagus	0.00035	0.00215	CcSEcCtD
Etoricoxib—Unspecified disorder of skin and subcutaneous tissue—Esomeprazole—Barrett's esophagus	0.000349	0.00215	CcSEcCtD
Etoricoxib—Unspecified disorder of skin and subcutaneous tissue—Omeprazole—Barrett's esophagus	0.000349	0.00215	CcSEcCtD
Etoricoxib—Dry mouth—Omeprazole—Barrett's esophagus	0.000344	0.00211	CcSEcCtD
Etoricoxib—Dry mouth—Esomeprazole—Barrett's esophagus	0.000344	0.00211	CcSEcCtD
Etoricoxib—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—Barrett's esophagus	0.00034	0.00878	CbGpPWpGaD
Etoricoxib—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP26A1—Barrett's esophagus	0.00034	0.00878	CbGpPWpGaD
Etoricoxib—Confusional state—Omeprazole—Barrett's esophagus	0.00034	0.00209	CcSEcCtD
Etoricoxib—Confusional state—Esomeprazole—Barrett's esophagus	0.00034	0.00209	CcSEcCtD
Etoricoxib—Anaphylactic shock—Omeprazole—Barrett's esophagus	0.000337	0.00207	CcSEcCtD
Etoricoxib—Anaphylactic shock—Esomeprazole—Barrett's esophagus	0.000337	0.00207	CcSEcCtD
Etoricoxib—Infection—Esomeprazole—Barrett's esophagus	0.000335	0.00206	CcSEcCtD
Etoricoxib—Infection—Omeprazole—Barrett's esophagus	0.000335	0.00206	CcSEcCtD
Etoricoxib—Shock—Esomeprazole—Barrett's esophagus	0.000332	0.00204	CcSEcCtD
Etoricoxib—Shock—Omeprazole—Barrett's esophagus	0.000332	0.00204	CcSEcCtD
Etoricoxib—MAPK14—digestive system—Barrett's esophagus	0.000331	0.153	CbGeAlD
Etoricoxib—Nervous system disorder—Omeprazole—Barrett's esophagus	0.000331	0.00203	CcSEcCtD
Etoricoxib—Nervous system disorder—Esomeprazole—Barrett's esophagus	0.000331	0.00203	CcSEcCtD
Etoricoxib—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP26A1—Barrett's esophagus	0.00033	0.00853	CbGpPWpGaD
Etoricoxib—Thrombocytopenia—Esomeprazole—Barrett's esophagus	0.00033	0.00203	CcSEcCtD
Etoricoxib—Thrombocytopenia—Omeprazole—Barrett's esophagus	0.00033	0.00203	CcSEcCtD
Etoricoxib—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP26A1—Barrett's esophagus	0.000328	0.00845	CbGpPWpGaD
Etoricoxib—Skin disorder—Omeprazole—Barrett's esophagus	0.000327	0.00201	CcSEcCtD
Etoricoxib—Skin disorder—Esomeprazole—Barrett's esophagus	0.000327	0.00201	CcSEcCtD
Etoricoxib—CYP2D6—Oxidation by Cytochrome P450—CYP26A1—Barrett's esophagus	0.000326	0.00841	CbGpPWpGaD
Etoricoxib—CYP2C9—Oxidation by Cytochrome P450—CYP26A1—Barrett's esophagus	0.000323	0.00834	CbGpPWpGaD
Etoricoxib—Anorexia—Omeprazole—Barrett's esophagus	0.000321	0.00198	CcSEcCtD
Etoricoxib—Anorexia—Esomeprazole—Barrett's esophagus	0.000321	0.00198	CcSEcCtD
Etoricoxib—PTGS2—Overview of nanoparticle effects—CXCL8—Barrett's esophagus	0.000312	0.00804	CbGpPWpGaD
Etoricoxib—MAPK14—CD40/CD40L signaling—RELA—Barrett's esophagus	0.00031	0.00801	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling mediated by p38-alpha and p38-beta—PTGS2—Barrett's esophagus	0.000308	0.00796	CbGpPWpGaD
Etoricoxib—Musculoskeletal discomfort—Omeprazole—Barrett's esophagus	0.000307	0.00189	CcSEcCtD
Etoricoxib—Musculoskeletal discomfort—Esomeprazole—Barrett's esophagus	0.000307	0.00189	CcSEcCtD
Etoricoxib—Insomnia—Esomeprazole—Barrett's esophagus	0.000305	0.00187	CcSEcCtD
Etoricoxib—Insomnia—Omeprazole—Barrett's esophagus	0.000305	0.00187	CcSEcCtD
Etoricoxib—Dyspnoea—Esomeprazole—Barrett's esophagus	0.000301	0.00185	CcSEcCtD
Etoricoxib—Dyspnoea—Omeprazole—Barrett's esophagus	0.000301	0.00185	CcSEcCtD
Etoricoxib—Somnolence—Omeprazole—Barrett's esophagus	0.0003	0.00184	CcSEcCtD
Etoricoxib—Somnolence—Esomeprazole—Barrett's esophagus	0.0003	0.00184	CcSEcCtD
Etoricoxib—Dyspepsia—Omeprazole—Barrett's esophagus	0.000297	0.00182	CcSEcCtD
Etoricoxib—Dyspepsia—Esomeprazole—Barrett's esophagus	0.000297	0.00182	CcSEcCtD
Etoricoxib—Decreased appetite—Omeprazole—Barrett's esophagus	0.000293	0.0018	CcSEcCtD
Etoricoxib—Decreased appetite—Esomeprazole—Barrett's esophagus	0.000293	0.0018	CcSEcCtD
Etoricoxib—CYP2C19—Phase 1 - Functionalization of compounds—CYP26A1—Barrett's esophagus	0.000291	0.00752	CbGpPWpGaD
Etoricoxib—Gastrointestinal disorder—Omeprazole—Barrett's esophagus	0.000291	0.00179	CcSEcCtD
Etoricoxib—Gastrointestinal disorder—Esomeprazole—Barrett's esophagus	0.000291	0.00179	CcSEcCtD
Etoricoxib—Fatigue—Omeprazole—Barrett's esophagus	0.000291	0.00179	CcSEcCtD
Etoricoxib—Fatigue—Esomeprazole—Barrett's esophagus	0.000291	0.00179	CcSEcCtD
Etoricoxib—Constipation—Esomeprazole—Barrett's esophagus	0.000288	0.00177	CcSEcCtD
Etoricoxib—Pain—Omeprazole—Barrett's esophagus	0.000288	0.00177	CcSEcCtD
Etoricoxib—Constipation—Omeprazole—Barrett's esophagus	0.000288	0.00177	CcSEcCtD
Etoricoxib—Pain—Esomeprazole—Barrett's esophagus	0.000288	0.00177	CcSEcCtD
Etoricoxib—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP26A1—Barrett's esophagus	0.00028	0.00722	CbGpPWpGaD
Etoricoxib—Feeling abnormal—Esomeprazole—Barrett's esophagus	0.000278	0.00171	CcSEcCtD
Etoricoxib—Feeling abnormal—Omeprazole—Barrett's esophagus	0.000278	0.00171	CcSEcCtD
Etoricoxib—CYP1A2—Oxidation by Cytochrome P450—CYP26A1—Barrett's esophagus	0.000276	0.00713	CbGpPWpGaD
Etoricoxib—Gastrointestinal pain—Esomeprazole—Barrett's esophagus	0.000276	0.0017	CcSEcCtD
Etoricoxib—Gastrointestinal pain—Omeprazole—Barrett's esophagus	0.000276	0.0017	CcSEcCtD
Etoricoxib—MAPK14—TWEAK Signaling Pathway—RELA—Barrett's esophagus	0.000274	0.00708	CbGpPWpGaD
Etoricoxib—CYP2D6—Phase 1 - Functionalization of compounds—CYP26A1—Barrett's esophagus	0.000268	0.00691	CbGpPWpGaD
Etoricoxib—Urticaria—Omeprazole—Barrett's esophagus	0.000268	0.00165	CcSEcCtD
Etoricoxib—Urticaria—Esomeprazole—Barrett's esophagus	0.000268	0.00165	CcSEcCtD
Etoricoxib—Abdominal pain—Omeprazole—Barrett's esophagus	0.000267	0.00164	CcSEcCtD
Etoricoxib—Abdominal pain—Esomeprazole—Barrett's esophagus	0.000267	0.00164	CcSEcCtD
Etoricoxib—CYP2C9—Phase 1 - Functionalization of compounds—CYP26A1—Barrett's esophagus	0.000266	0.00685	CbGpPWpGaD
Etoricoxib—MAPK14—TSLP Signaling Pathway—RELA—Barrett's esophagus	0.000251	0.00647	CbGpPWpGaD
Etoricoxib—MAPK14—Structural Pathway of Interleukin 1 (IL-1)—RELA—Barrett's esophagus	0.000251	0.00647	CbGpPWpGaD
Etoricoxib—Hypersensitivity—Esomeprazole—Barrett's esophagus	0.000248	0.00153	CcSEcCtD
Etoricoxib—Hypersensitivity—Omeprazole—Barrett's esophagus	0.000248	0.00153	CcSEcCtD
Etoricoxib—Asthenia—Esomeprazole—Barrett's esophagus	0.000242	0.00149	CcSEcCtD
Etoricoxib—Asthenia—Omeprazole—Barrett's esophagus	0.000242	0.00149	CcSEcCtD
Etoricoxib—CYP2E1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—Barrett's esophagus	0.000241	0.00623	CbGpPWpGaD
Etoricoxib—MAPK14—Angiopoietin receptor Tie2-mediated signaling—RELA—Barrett's esophagus	0.000239	0.00616	CbGpPWpGaD
Etoricoxib—MAPK14—Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways—RELA—Barrett's esophagus	0.000239	0.00616	CbGpPWpGaD
Etoricoxib—Pruritus—Omeprazole—Barrett's esophagus	0.000239	0.00147	CcSEcCtD
Etoricoxib—Pruritus—Esomeprazole—Barrett's esophagus	0.000239	0.00147	CcSEcCtD
Etoricoxib—MAPK14—TSLP Signaling Pathway—CXCL8—Barrett's esophagus	0.000236	0.0061	CbGpPWpGaD
Etoricoxib—MAPK14—Regulation of retinoblastoma protein—PPARG—Barrett's esophagus	0.000236	0.00609	CbGpPWpGaD
Etoricoxib—CYP3A4—Irinotecan Pathway—APC—Barrett's esophagus	0.000236	0.00609	CbGpPWpGaD
Etoricoxib—MAPK14—CDC42 signaling events—APC—Barrett's esophagus	0.000233	0.00602	CbGpPWpGaD
Etoricoxib—Diarrhoea—Esomeprazole—Barrett's esophagus	0.000231	0.00142	CcSEcCtD
Etoricoxib—Diarrhoea—Omeprazole—Barrett's esophagus	0.000231	0.00142	CcSEcCtD
Etoricoxib—CYP1A2—Phase 1 - Functionalization of compounds—CYP26A1—Barrett's esophagus	0.000227	0.00586	CbGpPWpGaD
Etoricoxib—MAPK14—IL-4 Signaling Pathway—RELA—Barrett's esophagus	0.000224	0.00579	CbGpPWpGaD
Etoricoxib—Dizziness—Omeprazole—Barrett's esophagus	0.000223	0.00137	CcSEcCtD
Etoricoxib—Dizziness—Esomeprazole—Barrett's esophagus	0.000223	0.00137	CcSEcCtD
Etoricoxib—MAPK14—RANKL/RANK Signaling Pathway—RELA—Barrett's esophagus	0.000221	0.00571	CbGpPWpGaD
Etoricoxib—MAPK14—IL-1 signaling pathway—RELA—Barrett's esophagus	0.000221	0.00571	CbGpPWpGaD
Etoricoxib—MAPK14—p53 pathway—CDKN2A—Barrett's esophagus	0.000217	0.00561	CbGpPWpGaD
Etoricoxib—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP26A1—Barrett's esophagus	0.000216	0.00557	CbGpPWpGaD
Etoricoxib—Vomiting—Omeprazole—Barrett's esophagus	0.000214	0.00132	CcSEcCtD
Etoricoxib—Vomiting—Esomeprazole—Barrett's esophagus	0.000214	0.00132	CcSEcCtD
Etoricoxib—CYP3A4—Oxidation by Cytochrome P450—CYP26A1—Barrett's esophagus	0.000213	0.0055	CbGpPWpGaD
Etoricoxib—Rash—Esomeprazole—Barrett's esophagus	0.000213	0.00131	CcSEcCtD
Etoricoxib—Rash—Omeprazole—Barrett's esophagus	0.000213	0.00131	CcSEcCtD
Etoricoxib—Dermatitis—Esomeprazole—Barrett's esophagus	0.000212	0.00131	CcSEcCtD
Etoricoxib—Dermatitis—Omeprazole—Barrett's esophagus	0.000212	0.00131	CcSEcCtD
Etoricoxib—Headache—Omeprazole—Barrett's esophagus	0.000211	0.0013	CcSEcCtD
Etoricoxib—Headache—Esomeprazole—Barrett's esophagus	0.000211	0.0013	CcSEcCtD
Etoricoxib—MAPK14—IL12-mediated signaling events—RELA—Barrett's esophagus	0.000206	0.00532	CbGpPWpGaD
Etoricoxib—CYP2E1—Biological oxidations—CYP26A1—Barrett's esophagus	0.0002	0.00517	CbGpPWpGaD
Etoricoxib—Nausea—Omeprazole—Barrett's esophagus	0.0002	0.00123	CcSEcCtD
Etoricoxib—Nausea—Esomeprazole—Barrett's esophagus	0.0002	0.00123	CcSEcCtD
Etoricoxib—MAPK14—Regulation of retinoblastoma protein—CDKN2A—Barrett's esophagus	0.000199	0.00513	CbGpPWpGaD
Etoricoxib—CYP2E1—Metapathway biotransformation—CYP26A1—Barrett's esophagus	0.000198	0.0051	CbGpPWpGaD
Etoricoxib—MAPK14—ATF-2 transcription factor network—CXCL8—Barrett's esophagus	0.000197	0.00508	CbGpPWpGaD
Etoricoxib—MAPK14—Oncostatin M Signaling Pathway—RELA—Barrett's esophagus	0.000193	0.00499	CbGpPWpGaD
Etoricoxib—MAPK14—AGE/RAGE pathway—RELA—Barrett's esophagus	0.000191	0.00493	CbGpPWpGaD
Etoricoxib—MAPK14—Rac1/Pak1/p38/MMP-2 pathway—RELA—Barrett's esophagus	0.000189	0.00487	CbGpPWpGaD
Etoricoxib—MAPK14—BCR signaling pathway—RELA—Barrett's esophagus	0.000189	0.00487	CbGpPWpGaD
Etoricoxib—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—PPARG—Barrett's esophagus	0.000188	0.00486	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling mediated by p38-alpha and p38-beta—TP53—Barrett's esophagus	0.000184	0.00474	CbGpPWpGaD
Etoricoxib—CYP3A4—Phase 1 - Functionalization of compounds—CYP26A1—Barrett's esophagus	0.000175	0.00452	CbGpPWpGaD
Etoricoxib—MAPK14—TRAF6 Mediated Induction of proinflammatory cytokines—RELA—Barrett's esophagus	0.000173	0.00445	CbGpPWpGaD
Etoricoxib—MAPK14—Leptin signaling pathway—RELA—Barrett's esophagus	0.000173	0.00445	CbGpPWpGaD
Etoricoxib—MAPK14—Amyotrophic lateral sclerosis (ALS)—TP53—Barrett's esophagus	0.000172	0.00444	CbGpPWpGaD
Etoricoxib—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—Barrett's esophagus	0.00017	0.00438	CbGpPWpGaD
Etoricoxib—MAPK14—p73 transcription factor network—RELA—Barrett's esophagus	0.000165	0.00427	CbGpPWpGaD
Etoricoxib—PTGS2—Aryl Hydrocarbon Receptor—RELA—Barrett's esophagus	0.000163	0.00421	CbGpPWpGaD
Etoricoxib—MAPK14—Glucocorticoid receptor regulatory network—RELA—Barrett's esophagus	0.000161	0.00415	CbGpPWpGaD
Etoricoxib—MAPK14—MyD88 cascade initiated on plasma membrane—RELA—Barrett's esophagus	0.000156	0.00403	CbGpPWpGaD
Etoricoxib—CYP2C19—Biological oxidations—CYP26A1—Barrett's esophagus	0.000155	0.00399	CbGpPWpGaD
Etoricoxib—MAPK14—TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation—RELA—Barrett's esophagus	0.000155	0.00399	CbGpPWpGaD
Etoricoxib—CYP2C19—Metapathway biotransformation—CYP26A1—Barrett's esophagus	0.000153	0.00394	CbGpPWpGaD
Etoricoxib—MAPK14—MyD88 dependent cascade initiated on endosome—RELA—Barrett's esophagus	0.000152	0.00392	CbGpPWpGaD
Etoricoxib—MAPK14—Glucocorticoid receptor regulatory network—CXCL8—Barrett's esophagus	0.000151	0.00391	CbGpPWpGaD
Etoricoxib—MAPK14—TCR Signaling Pathway—RELA—Barrett's esophagus	0.000149	0.00385	CbGpPWpGaD
Etoricoxib—MAPK14—Toll Like Receptor 9 (TLR9) Cascade—RELA—Barrett's esophagus	0.000147	0.00378	CbGpPWpGaD
Etoricoxib—MAPK14—Corticotropin-releasing hormone—RELA—Barrett's esophagus	0.000147	0.00378	CbGpPWpGaD
Etoricoxib—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—Barrett's esophagus	0.000145	0.00374	CbGpPWpGaD
Etoricoxib—MAPK14—MyD88:Mal cascade initiated on plasma membrane—RELA—Barrett's esophagus	0.000144	0.00372	CbGpPWpGaD
Etoricoxib—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CXCL8—Barrett's esophagus	0.000144	0.00371	CbGpPWpGaD
Etoricoxib—CYP2D6—Biological oxidations—CYP26A1—Barrett's esophagus	0.000142	0.00367	CbGpPWpGaD
Etoricoxib—CYP2C9—Biological oxidations—CYP26A1—Barrett's esophagus	0.000141	0.00364	CbGpPWpGaD
Etoricoxib—CYP2C19—digestive system—Barrett's esophagus	0.000141	0.0651	CbGeAlD
Etoricoxib—MAPK14—B Cell Receptor Signaling Pathway—RELA—Barrett's esophagus	0.00014	0.00362	CbGpPWpGaD
Etoricoxib—CYP2D6—Metapathway biotransformation—CYP26A1—Barrett's esophagus	0.00014	0.00362	CbGpPWpGaD
Etoricoxib—CYP2C9—Metapathway biotransformation—CYP26A1—Barrett's esophagus	0.000139	0.00359	CbGpPWpGaD
Etoricoxib—MAPK14—MyD88-independent cascade—RELA—Barrett's esophagus	0.000138	0.00357	CbGpPWpGaD
Etoricoxib—MAPK14—Corticotropin-releasing hormone—CXCL8—Barrett's esophagus	0.000138	0.00356	CbGpPWpGaD
Etoricoxib—MAPK14—Senescence and Autophagy in Cancer—CDKN2A—Barrett's esophagus	0.000137	0.00354	CbGpPWpGaD
Etoricoxib—MAPK14—Toll-like Receptor Signaling Pathway—RELA—Barrett's esophagus	0.000135	0.00348	CbGpPWpGaD
Etoricoxib—MAPK14—BDNF signaling pathway—APC—Barrett's esophagus	0.000131	0.00338	CbGpPWpGaD
Etoricoxib—MAPK14—Toll-like Receptor Signaling Pathway—CXCL8—Barrett's esophagus	0.000127	0.00328	CbGpPWpGaD
Etoricoxib—MAPK14—Platelet activation, signaling and aggregation—HGF—Barrett's esophagus	0.000125	0.00323	CbGpPWpGaD
Etoricoxib—PTGS2—epithelium—Barrett's esophagus	0.000125	0.0579	CbGeAlD
Etoricoxib—MAPK14—Activated TLR4 signalling—RELA—Barrett's esophagus	0.000124	0.00321	CbGpPWpGaD
Etoricoxib—MAPK14—Senescence and Autophagy in Cancer—CXCL8—Barrett's esophagus	0.000124	0.00321	CbGpPWpGaD
Etoricoxib—MAPK14—Oxidative Stress Induced Senescence—CDKN2A—Barrett's esophagus	0.000124	0.0032	CbGpPWpGaD
Etoricoxib—MAPK14—p53 pathway—TP53—Barrett's esophagus	0.000121	0.00312	CbGpPWpGaD
Etoricoxib—PTGS2—smooth muscle tissue—Barrett's esophagus	0.000121	0.0558	CbGeAlD
Etoricoxib—CYP1A2—Biological oxidations—CYP26A1—Barrett's esophagus	0.000121	0.00311	CbGpPWpGaD
Etoricoxib—CYP1A2—Metapathway biotransformation—CYP26A1—Barrett's esophagus	0.000119	0.00307	CbGpPWpGaD
Etoricoxib—PTGS2—Signaling mediated by p38-alpha and p38-beta—TP53—Barrett's esophagus	0.000117	0.00303	CbGpPWpGaD
Etoricoxib—MAPK14—Toll Like Receptor 4 (TLR4) Cascade—RELA—Barrett's esophagus	0.000117	0.00302	CbGpPWpGaD
Etoricoxib—CYP1A2—digestive system—Barrett's esophagus	0.000115	0.0532	CbGeAlD
Etoricoxib—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—Barrett's esophagus	0.000112	0.00289	CbGpPWpGaD
Etoricoxib—MAPK14—Oncostatin M Signaling Pathway—TP53—Barrett's esophagus	0.000112	0.00289	CbGpPWpGaD
Etoricoxib—MAPK14—Rac1/Pak1/p38/MMP-2 pathway—TP53—Barrett's esophagus	0.000109	0.00282	CbGpPWpGaD
Etoricoxib—CYP2C9—digestive system—Barrett's esophagus	0.000109	0.0505	CbGeAlD
Etoricoxib—PTGS2—Metabolism of lipids and lipoproteins—PTGES—Barrett's esophagus	0.000108	0.00279	CbGpPWpGaD
Etoricoxib—CYP2C19—Arachidonic acid metabolism—PTGS2—Barrett's esophagus	0.000108	0.00278	CbGpPWpGaD
Etoricoxib—MAPK14—Regulation of toll-like receptor signaling pathway—RELA—Barrett's esophagus	0.000105	0.00272	CbGpPWpGaD
Etoricoxib—PTGS2—C-MYB transcription factor network—CDKN2A—Barrett's esophagus	0.000105	0.0027	CbGpPWpGaD
Etoricoxib—MAPK14—Integrated Pancreatic Cancer Pathway—APC—Barrett's esophagus	0.000105	0.0027	CbGpPWpGaD
Etoricoxib—MAPK14—Toll-Like Receptors Cascades—RELA—Barrett's esophagus	0.000104	0.00269	CbGpPWpGaD
Etoricoxib—CYP2E1—digestive system—Barrett's esophagus	0.000103	0.0479	CbGeAlD
Etoricoxib—MAPK14—BDNF signaling pathway—RELA—Barrett's esophagus	0.000102	0.00264	CbGpPWpGaD
Etoricoxib—MAPK14—Regulation of toll-like receptor signaling pathway—CXCL8—Barrett's esophagus	9.92e-05	0.00256	CbGpPWpGaD
Etoricoxib—CYP2C9—Arachidonic acid metabolism—PTGS2—Barrett's esophagus	9.81e-05	0.00253	CbGpPWpGaD
Etoricoxib—PTGS2—Selenium Micronutrient Network—RELA—Barrett's esophagus	9.7e-05	0.0025	CbGpPWpGaD
Etoricoxib—PTGS2—digestive system—Barrett's esophagus	9.53e-05	0.0441	CbGeAlD
Etoricoxib—CYP3A4—Biological oxidations—CYP26A1—Barrett's esophagus	9.3e-05	0.0024	CbGpPWpGaD
Etoricoxib—MAPK14—Glucocorticoid receptor regulatory network—TP53—Barrett's esophagus	9.29e-05	0.0024	CbGpPWpGaD
Etoricoxib—CYP1A2—Aryl Hydrocarbon Receptor—RELA—Barrett's esophagus	9.22e-05	0.00238	CbGpPWpGaD
Etoricoxib—CYP3A4—Metapathway biotransformation—CYP26A1—Barrett's esophagus	9.17e-05	0.00237	CbGpPWpGaD
Etoricoxib—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—Barrett's esophagus	8.96e-05	0.00231	CbGpPWpGaD
Etoricoxib—MAPK14—Cellular Senescence—CDKN2A—Barrett's esophagus	8.67e-05	0.00224	CbGpPWpGaD
Etoricoxib—CYP1A2—Arachidonic acid metabolism—PTGS2—Barrett's esophagus	8.38e-05	0.00216	CbGpPWpGaD
Etoricoxib—MAPK14—Cellular Senescence—RELA—Barrett's esophagus	8.34e-05	0.00215	CbGpPWpGaD
Etoricoxib—CYP3A4—digestive system—Barrett's esophagus	8.33e-05	0.0385	CbGeAlD
Etoricoxib—CYP2D6—digestive system—Barrett's esophagus	8.19e-05	0.0379	CbGeAlD
Etoricoxib—MAPK14—Integrated Pancreatic Cancer Pathway—PTGS2—Barrett's esophagus	7.94e-05	0.00205	CbGpPWpGaD
Etoricoxib—MAPK14—Cellular Senescence—CXCL8—Barrett's esophagus	7.86e-05	0.00203	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism of lipids and lipoproteins—PTGES—Barrett's esophagus	7.84e-05	0.00202	CbGpPWpGaD
Etoricoxib—MAPK14—Senescence and Autophagy in Cancer—TP53—Barrett's esophagus	7.62e-05	0.00197	CbGpPWpGaD
Etoricoxib—MAPK14—Gene Expression—NR1I2—Barrett's esophagus	7.33e-05	0.00189	CbGpPWpGaD
Etoricoxib—PTGS2—Spinal Cord Injury—CXCL8—Barrett's esophagus	7.23e-05	0.00187	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism of lipids and lipoproteins—PTGES—Barrett's esophagus	7.15e-05	0.00184	CbGpPWpGaD
Etoricoxib—MAPK14—Oxidative Stress Induced Senescence—TP53—Barrett's esophagus	6.9e-05	0.00178	CbGpPWpGaD
Etoricoxib—PTGS2—Integrated Pancreatic Cancer Pathway—APC—Barrett's esophagus	6.68e-05	0.00172	CbGpPWpGaD
Etoricoxib—MAPK14—Cellular responses to stress—CDKN2A—Barrett's esophagus	6.55e-05	0.00169	CbGpPWpGaD
Etoricoxib—MAPK14—Hemostasis—HGF—Barrett's esophagus	6.46e-05	0.00167	CbGpPWpGaD
Etoricoxib—MAPK14—TGF-beta Signaling Pathway—TP53—Barrett's esophagus	6.35e-05	0.00164	CbGpPWpGaD
Etoricoxib—MAPK14—Cellular responses to stress—RELA—Barrett's esophagus	6.3e-05	0.00163	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism of lipids and lipoproteins—PTGES—Barrett's esophagus	6.11e-05	0.00158	CbGpPWpGaD
Etoricoxib—MAPK14—Cellular responses to stress—CXCL8—Barrett's esophagus	5.94e-05	0.00153	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling by NGF—RELA—Barrett's esophagus	5.91e-05	0.00153	CbGpPWpGaD
Etoricoxib—MAPK14—MAPK Signaling Pathway—TP53—Barrett's esophagus	5.23e-05	0.00135	CbGpPWpGaD
Etoricoxib—MAPK14—Cellular Senescence—TP53—Barrett's esophagus	4.82e-05	0.00125	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism—PTGES—Barrett's esophagus	4.81e-05	0.00124	CbGpPWpGaD
Etoricoxib—MAPK14—Integrated Pancreatic Cancer Pathway—TP53—Barrett's esophagus	4.72e-05	0.00122	CbGpPWpGaD
Etoricoxib—MAPK14—Developmental Biology—PPARG—Barrett's esophagus	4.72e-05	0.00122	CbGpPWpGaD
Etoricoxib—CYP2E1—Metabolism—PTGES—Barrett's esophagus	4.52e-05	0.00117	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—GAST—Barrett's esophagus	4.48e-05	0.00116	CbGpPWpGaD
Etoricoxib—PTGS2—Spinal Cord Injury—TP53—Barrett's esophagus	4.44e-05	0.00114	CbGpPWpGaD
Etoricoxib—MAPK14—Developmental Biology—RELA—Barrett's esophagus	3.82e-05	0.000986	CbGpPWpGaD
Etoricoxib—MAPK14—Cellular responses to stress—TP53—Barrett's esophagus	3.65e-05	0.000941	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism—CYP26A1—Barrett's esophagus	3.64e-05	0.00094	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—PTGES—Barrett's esophagus	3.49e-05	0.000901	CbGpPWpGaD
Etoricoxib—CYP2E1—Metabolism—CYP26A1—Barrett's esophagus	3.43e-05	0.000885	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—HGF—Barrett's esophagus	3.39e-05	0.000874	CbGpPWpGaD
Etoricoxib—MAPK14—Innate Immune System—RELA—Barrett's esophagus	3.37e-05	0.00087	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—PTGES—Barrett's esophagus	3.21e-05	0.000829	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—PTGES—Barrett's esophagus	3.18e-05	0.000821	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—SLC9A1—Barrett's esophagus	3.13e-05	0.000809	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—SST—Barrett's esophagus	3.07e-05	0.000793	CbGpPWpGaD
Etoricoxib—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—Barrett's esophagus	3.02e-05	0.000779	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—PTGES—Barrett's esophagus	2.72e-05	0.000702	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism of lipids and lipoproteins—PPARG—Barrett's esophagus	2.69e-05	0.000695	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—CYP26A1—Barrett's esophagus	2.65e-05	0.000683	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism—SLC9A1—Barrett's esophagus	2.63e-05	0.000678	CbGpPWpGaD
Etoricoxib—CYP2E1—Metabolism—SLC9A1—Barrett's esophagus	2.47e-05	0.000638	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—CYP26A1—Barrett's esophagus	2.43e-05	0.000628	CbGpPWpGaD
Etoricoxib—MAPK14—Gene Expression—PPARG—Barrett's esophagus	2.41e-05	0.000623	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—CYP26A1—Barrett's esophagus	2.41e-05	0.000623	CbGpPWpGaD
Etoricoxib—MAPK14—Hemostasis—TP53—Barrett's esophagus	2.17e-05	0.000559	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—PTGES—Barrett's esophagus	2.1e-05	0.000542	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—CYP26A1—Barrett's esophagus	2.06e-05	0.000532	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—RELA—Barrett's esophagus	1.96e-05	0.000507	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—Barrett's esophagus	1.95e-05	0.000504	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—SLC9A1—Barrett's esophagus	1.91e-05	0.000492	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—Barrett's esophagus	1.78e-05	0.00046	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—SLC9A1—Barrett's esophagus	1.75e-05	0.000453	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—SLC9A1—Barrett's esophagus	1.74e-05	0.000449	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—APC—Barrett's esophagus	1.63e-05	0.000419	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—CYP26A1—Barrett's esophagus	1.59e-05	0.000411	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—Barrett's esophagus	1.54e-05	0.000397	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—Barrett's esophagus	1.52e-05	0.000393	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—SLC9A1—Barrett's esophagus	1.49e-05	0.000383	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—APC—Barrett's esophagus	1.48e-05	0.000383	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—Barrett's esophagus	1.4e-05	0.000362	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—RELA—Barrett's esophagus	1.27e-05	0.000328	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism—PPARG—Barrett's esophagus	1.2e-05	0.000309	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—Barrett's esophagus	1.2e-05	0.000309	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—CXCL8—Barrett's esophagus	1.2e-05	0.000309	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—SLC9A1—Barrett's esophagus	1.15e-05	0.000296	CbGpPWpGaD
Etoricoxib—CYP2E1—Metabolism—PPARG—Barrett's esophagus	1.13e-05	0.000291	CbGpPWpGaD
Etoricoxib—CYP2E1—Metabolism—PTGS2—Barrett's esophagus	8.88e-06	0.000229	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—PPARG—Barrett's esophagus	8.7e-06	0.000225	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—PPARG—Barrett's esophagus	8.01e-06	0.000207	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—PPARG—Barrett's esophagus	7.94e-06	0.000205	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—TP53—Barrett's esophagus	7.34e-06	0.00019	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—PTGS2—Barrett's esophagus	6.85e-06	0.000177	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—PPARG—Barrett's esophagus	6.78e-06	0.000175	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—PTGS2—Barrett's esophagus	6.3e-06	0.000163	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—PTGS2—Barrett's esophagus	6.24e-06	0.000161	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—PTGS2—Barrett's esophagus	5.34e-06	0.000138	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—PPARG—Barrett's esophagus	5.23e-06	0.000135	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—PTGS2—Barrett's esophagus	4.12e-06	0.000106	CbGpPWpGaD
